Clarus Capital increased its exposure to a sponsor-backed medical device manufacturer by $10 million. Financing proceeds replenished liquidity recently utilized to acquire machining centers installed across multiple locations to support long-term contracts with major OEMs.
“Clarus’ sale leaseback facility, closed in under 30 days, included reimbursement for multiple precision manufacturing assets,” Steve O’Leary, CEO of Clarus Capital, said. “This investment serves as a continuation of Clarus’ growing expertise within the medical device manufacturing market, having deployed $50M of capital to multiple scaled manufacturers.”
“Clarus continues to execute thoughtful and reliable financing solutions for financial sponsors and their portfolio companies,” Jake Skivington, managing director – sponsor coverage at Clarus Capital, said. “This transaction in particular showcases Clarus’ ability to partner and scale with our clients in support of their evolving strategic objectives.”
